NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/15/2025
Back to search
Official data from USPTO
VYRIPHARM BIOPHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VYRIPHARM BIOPHARMACEUTICALS
ST13
US500000087837447Class
42
Filing
87837447
Registration
5742875
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
09/16/2025
Trademark type
Word
Nice classes
42
Filing date
03/16/2018
Registration date
05/07/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/15/2025
Last transaction
09/16/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
09/28/2014
First use in commerce
09/28/2014
Drawing code
4
Owner type
16
Owner location
Houston, TX
Examiner
FRIEDMAN, LESLEE
Current location
Historical data usage
Holders and representatives
Holders
Vyripharm Enterprises LLC
Representatives
Tasha Snipes Polsinelli PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical products development and testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
28 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/15/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/15/2025
E815
TEAS SECTION 8 & 15 RECEIVED
05/05/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/07/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/20/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/20/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/20/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/20/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/20/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/09/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/09/2019
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
09/06/2019
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
09/06/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
05/07/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/19/2019
PUBO
PUBLISHED FOR OPPOSITION
02/19/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/30/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/02/2018
GNRT
NON-FINAL ACTION E-MAILED
07/02/2018
CNRT
NON-FINAL ACTION WRITTEN
07/02/2018
DOCK
ASSIGNED TO EXAMINER
06/27/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/23/2018
NWAP
NEW APPLICATION ENTERED
03/20/2018
Continuous trademark protection
Get notified about every new filing that threatens VYRIPHARM BIOPHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.